Item 4. Controls and Procedures.

Controls and Procedures.

We,

under the

supervision and

with the

participation of

our management,

including our

Chief Executive

Officer and

Chief Financial

Officer,

have

evaluated

the

effectiveness

of

the design

and

operation

of

our

disclosure

controls

and

procedures

(as

defined

in

Rule

13a-15(e)

under

the

Securities

Exchange

Act

of

1934).

Based

on

our

evaluation,

our

Chief

Executive

Officer

and

Chief

Financial

Officer have concluded

that, as of February

23, 2025, our disclosure

controls and procedures were

effective to ensure

that information

required to

be disclosed

by us

in reports

that we file

or submit

under the

Securities Exchange

Act of

1934 is (1)

recorded, processed,

summarized,

and

reported

within

the

time

periods

specified

in

Securities

and

Exchange

Commission

rules

and

forms,

and

(2)

accumulated and

communicated to

our management,

including our

Chief Executive

Officer and

Chief Financial

Officer,

in a

manner

that allows timely decisions regarding required disclosure.

There were no changes in our internal

control over financial reporting (as defined

in Rule 13a-15(f) under the Securities Exchange

Act

of 1934) during the quarter

ended February 23, 2025, that

materially affected, or are

reasonably likely to materially

affect, our internal

control over financial reporting.

PART

II.

OTHER INFORMATION

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

The

following

table

sets forth

information

with

respect

to

shares

of

our

common

stock

that we

purchased

during

the quarter

ended

February 23, 2025:

Period

Total

Number

of Shares

Purchased (a)

Average

Price Paid

Per Share

Total

Number of Shares

Purchased as Part of a Publicly

Announced Program (b)

Maximum Number of Shares

that may yet be Purchased

Under the Program (b)

November 25, 2024 -

December 29, 2024

1,910,552

$

66.25

1,910,552

45,034,753

December 30, 2024 -

January 26, 2025

2,254,605

61.24

2,254,605

42,780,148

January 27, 2025 -

February 23, 2025

644,987

61.64

644,987

42,135,161

Total

4,810,144

$

63.28

4,810,144

42,135,161

(a)

The total number

of shares purchased

includes shares of

common stock withheld

for the payment

of withholding taxes

upon the distribution

of

deferred option units.

(b)

On June

27, 2022,

our Board

of Directors approved

an authorization

for the

repurchase of

up to

100,000,000 shares of

our common stock

and

terminated the

prior authorization.

Purchases can

be made

in the

open market

or in

privately negotiated

transactions, including

the use

of call

options

and

other

derivative

instruments,

Rule

10b5-1

trading

plans,

and

accelerated

repurchase

programs.

The

Board

did

not

specify

an

expiration date for the authorization.